Australian Statistics on Medicines 2010

Table 1 - Nervous System

NERVOUS SYSTEM

N01 - ANAESTHETICS
N02 - ANALGESICS
N03 - ANTIEPILEPTICS
N04 - ANTI-PARKINSON DRUGS
N05 - PSYCHOLEPTICS
N06 - PSYCHOANALEPTICS
N07 - OTHER NERVOUS SYSTEM DRUGS

N01 - ANAESTHETICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANAESTHETICS ANAESTHETICS, GENERAL OPIOID ANAESTHETICS
N01AH01	FENTANYL
	A	14186	Ampoule 100ug/2 5	—	—	561	—
ANAESTHETICS, LOCAL
AMIDES
N01BB02	LIGNOCAINE HYDROCHLORIDE
	A	15900	Ampoule 2% 2mL 50	—	—	120	—
N01BB52	LIGNOCAINE with ADRENALINE
	A	15905	Vial 2% 20mL 5	—	—	164	—

N02 - ANALGESICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANALGESICS OPIOIDS NATURAL OPIUM ALKALOIDS
N02AA59	CODEINE with ASPIRIN
	A	10090	Tablet soluble 8mg-300mg 20	—	—	4,216	—
	A	10091	Tablet soluble 8mg-300mg 100	—	—	452	—
	A	10466	Tablet soluble 8mg-500mg 24	—	—	786	—
	A	21158	Tablet soluble 9.5mg-500mg 24	—	—	522	—
	A	21174	Tablet soluble 8mg-300mg 40	—	—	548	—
	P	4061R	Tablet soluble 8mg-300mg 50	—	—	1,753	25,370
N02AA59	CODEINE with PARACETAMOL
	A	11705	Capsule 8mg-500mg 50	—	—	3,978	—
	A	11706	Tablet 8mg-500mg 100	—	—	14,134	—
	A	11755	Tablet soluble 8mg-500mg 24	—	—	2,895	—
	P	1215Y	Tablet 30mg-500mg 20	—	—	2,532,289	20,737,079
	A	12670	Tablet 8mg-500mg 20	—	—	125	—
	A	12736	Tablet 30mg-500mg 50	—	—	1,898	—
	A	14788	Tablet 8mg-500mg 100	—	—	879	—
	A	17212	Tablet 9.6mg-500mg 48	—	—	1,376	—
	A	17267	Caplet 8mg-500mg 48	—	—	3,486	—
	A	17819	Tablet 8mg-500mg 24	—	—	4,467	—
	A	17820	Tablet 8mg-500mg 48	—	—	6,138	—
	A	18373	Tablet 8mg-500mg 24	—	—	12,012	—
	A	18374	Tablet 8mg-500mg 48	—	—	541	—
	A	18375	Tablet 8mg-500mg 50	—	—	241	—
	A	18376	Tablet 8mg-500mg 96	—	—	634	—
	A	18377	Tablet 8mg-500mg 100	—	—	1,668	—
	A	18378	Tabsule 8mg-500mg 24	—	—	862	—
	A	18380	Tabsule 8mg-500mg 96	—	—	110	—
	A	18734	Tablet 15mg-500mg 12	—	—	41,751	—
	A	19039	Caplet 8mg-500mg 24	—	—	8,505	—
	A	19041	Tablet 8mg-500mg 24	—	—	17,520	—
	A	20658	Tablet 10mg-500mg 48	—	—	193	—
	A	21096	Tablet 9.6mg-500mg 36	—	—	634	—
	A	21097	Tablet 9.6mg-500mg 24	—	—	9,517	—
	A	21098	Tablet 9.6mg-500mg 12	—	—	487	—
	A	21111	Tablet 10mg-500mg 40	—	—	7,019	—
	A	21112	Tabsule 10mg-500mg 40	—	—	250	—
	A	21113	Tablet 10mg-500mg 40	—	—	398	—
	A	21146	Tablet 10mg-500mg 40	—	—	425	—
	A	21168	Tablet 8mg-500mg 40	—	—	187	—
	A	21173	Tablet 8mg-500mg 40	—	—	424	—
	A	21224	Tablet 10mg-500mg 40	—	—	138	—
	A	21225	Caplet 8mg-500mg 40	—	—	2,481	—
	A	21226	Tablet 8mg-500mg 40	—	—	9,462	—

N02 - ANALGESICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANALGESICS OPIOIDS
	A	21227	Caplet 15mg-500mg 24	—	—	6,621	—
	A	21240	Tablet 10mg-500mg 24	—	—	265	—
	P	3316M	Tablet 30mg-500mg 20	—	—	150,246	1,212,413
	P	4170L	Tablet 15mg-500mg 20	—	—	14,451	190,187
	P	4171M	Tablet 8mg-500mg	—	—	19,885	263,519
	P	8785J	Tablet 30mg-500mg 60	—	—	993,983	17,398,031
N02AA08	DIHYDROCODEINE
	A	11785	Linctus 200mL 1	—	—	10,174	—
	A	12825	Linctus 100mL 1	—	—	5,818	—
N02AA03	HYDROMORPHONE
	P	8420E	Injection 2mg in 1mL 5	4.00	MG	3,548	173,811
	P	8421F	Injection 10mg in 1mL 5	4.00	MG	2,865	288,170
	P	8422G	Injection 50mg in 5mL 5	4.00	MG	2,147	304,537
	P	8423H	Injection 500mg in 50mL	4.00	MG	193	19,106
	P	8424J	Oral liquid 1mg per mL 473mL	20.00	MG	4,634	353,611
	P	8541M	Tablet 2mg 20	20.00	MG	2,249	56,563
	P	8542N	Tablet 4mg	20.00	MG	2,307	88,474
	P	8543P	Tablet 8mg	20.00	MG	2,565	222,311
	P	9299K	Tablet 4mg (modified release) 10	20.00	MG	6,307	221,215
	P	9406C	Tablet 8mg (modified release) 10	20.00	MG	9,020	427,476
	P	9407D	Tablet 16mg (modified release) 10	20.00	MG	7,787	535,885
	P	9408E	Tablet 32mg (modified release) 10	20.00	MG	4,571	535,427
	P	9409F	Tablet 64mg (modified release) 10	20.00	MG	2,534	745,708
N02AA01	MORPHINE
	A	13087	Ampoule 5mg/mL 5	30.00	MG	3,168	—
	A	14931	Capsule 20mg (sustained release)	100.00	MG	138	—
	A	15415	Mixture 200mL 1mg per mL	100.00	MG	398	—
	P	1607N	Injection 120mg in 1.5mL	30.00	MG	2,929	414,685
	P	1644M	Injection 10mg in 1mL	30.00	MG	68,269	1,169,060
	P	1645N	Injection 15mg in 1mL	30.00	MG	13,097	313,153
	P	1646P	Tablet 30mg	100.00	MG	12,270	269,195
	P	1647Q	Injection 30mg in 1mL	30.00	MG	26,747	975,036
	P	1653B	Tablet 10mg (controlled release)	100.00	MG	74,573	2,057,720
	P	1654C	Tablet 30mg (controlled release)	100.00	MG	79,899	4,162,242
	P	1655D	Tablet 60mg (controlled release)	100.00	MG	62,864	5,251,476
	P	1656E	Tablet 100mg (controlled release)	100.00	MG	56,937	6,755,862
	A	19608	Injection 10mg in 1mL	30.00	MG	123	—
	A	19620	Injection 15mg in 1mL	30.00	MG	114	—
	P	2122Q	Oral solution 2mg per mL 200mL	100.00	MG	17,940	327,105
	P	2123R	Oral solution 5mg per mL 200mL	100.00	MG	28,563	617,346
	P	2124T	Oral solution 10mg per mL 200mL	100.00	MG	29,334	935,787
	P	2839K	Capsule 20mg (sustained release)	100.00	MG	49,895	1,958,565
	P	2840L	Capsule 50mg (sustained release)	100.00	MG	41,369	2,556,125

N02 - ANALGESICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANALGESICS OPIOIDS
	P	2841M	Capsule 100mg (sustained release)	100.00	MG	31,114	3,733,899
	P	3479D	Injection 15mg in 1mL	30.00	MG	8,730	126,671
	P	3480E	Injection 30mg in 1mL	30.00	MG	3,840	61,343
	P	8035X	Tablet 5mg (controlled release)	100.00	MG	28,156	533,111
	P	8146R	Sachet 30mg (controlled release)	100.00	MG	1,122	95,495
	P	8305D	Sachet 60mg granules for oral suspn	100.00	MG	902	88,105
	P	8306E	Sachet 100mg granules for oral suspn	100.00	MG	384	56,958
	P	8349K	Capsule 10mg (sustained release) 20	100.00	MG	22,680	558,349
	P	8453X	Tablet 200mg (controlled release)	100.00	MG	718	243,986
	P	8489T	Tablet 15mg (controlled release) 20	100.00	MG	35,966	1,121,557
	P	8490W	Sachet 20mg granules for oral suspn 20	100.00	MG	2,629	212,607
	P	8491X	Capsule 30mg (controlled release) 10	100.00	MG	2,354	75,793
	P	8492Y	Capsule 60mg (controlled release) 10	100.00	MG	3,101	157,188
	P	8493B	Capsule 90mg (controlled release) 10	100.00	MG	2,518	184,513
	P	8494C	Capsule 120mg (controlled release) 10	100.00	MG	3,265	398,906
	P	8669G	Tablet 10mg 20	100.00	MG	1,062	16,943
	P	8670H	Tablet 20mg 20	100.00	MG	812	16,763
N02AA05	OXYCODONE
	P	2481N	Suppository 30mg	30.00	MG	9,844	887,243
	P	2622B	Tablet 5mg	75.00	MG	1,085,921	15,495,646
	P	5195K	Tablet 5mg	75.00	MG	1,123	13,702
	P	8385H	Tablet 10mg (controlled release) 20	75.00	MG	392,123	11,840,367
	P	8386J	Tablet 20mg (controlled release) 20	75.00	MG	334,317	17,689,338
	P	8387K	Tablet 40mg (controlled release) 20	75.00	MG	219,120	18,949,128
	P	8388L	Tablet 80mg (controlled release) 20	75.00	MG	126,427	17,403,019
	P	8464L	Capsule 5mg 20	75.00	MG	81,185	1,138,359
	P	8501K	Capsule 10mg 20	75.00	MG	108,966	2,343,355
	P	8502L	Capsule 20mg 20	75.00	MG	77,057	2,916,308
	P	8644Y	Oral solution 5mg per 5mL 250mL	75.00	MG	10,027	275,381
	P	8681X	Tablet 5mg (controlled release) 20	75.00	MG	203,043	5,405,529
	P	9399Q	Tablet 15mg (controlled release) 20	75.00	MG	60,631	2,426,466
	P	9400R	Tablet 30mg (controlled release) 20	75.00	MG	78,023	5,451,747
PHENYLPIPERIDINE DERIVATIVES
N02AB03	FENTANYL
	P	5401G	Lozenge 200ug 3	0.60	MG	783	225,109
	P	5402H	Lozenge 400ug 3	0.60	MG	330	107,076
	P	5407N	Lozenges 200ug (as citrate) 3 20	0.60	MG	270	198,432
	P	5408P	Lozenges 400ug (as citrate) 3 20	0.60	MG	204	151,864
	P	5413X	Lozenge 200ug 3	0.60	MG	366	312,566
	P	5414Y	Lozenge 400ug 3	0.60	MG	371	343,329
	P	5415B	Lozenge 600ug 3	0.60	MG	115	104,710
	P	5416C	Lozenge 800ug 3	0.60	MG	145	164,758
	P	8878G	Transdermal patch 2.1mg (12ug per hour) 5	1.20	MG	155,692	8,624,655

N02 - ANALGESICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANALGESICS OPIOIDS
	P	8891Y	Transdermal patch 4.2mg (25ug per hour) 5	1.20	MG	177,366	12,258,905
	P	8892B	Transdermal patch 8.4mg (50ug per hour) 5	1.20	MG	110,947	13,464,219
	P	8893C	Transdermal patch 12.6mg (75ug per hour) 5	1.20	MG	55,704	9,262,902
	P	8894D	Transdermal patch 16.8mg (100ug per hour) 5	1.20	MG	55,315	12,686,214
N02AB02	PETHIDINE HYDROCHLORIDE
	A	15888	Injection 100mg in 2mL 10	0.40	GM	2,389	—
	A	18990	Injection 100mg in 2mL	0.40	GM	6,385	—
	A	19593	Injection 50mg in 1mL	0.40	GM	887	—
	A	19982	Injection 100mg in 2mL 5	0.40	GM	9,329	—
DIPHENYLPROPYLAMINE DERIVATIVES
N02AC04	DEXTROPROPOXYPHENE NAPSYLATE
	P	4081T	Capsule 100mg	0.30	GM	21,791	598,380
N02AC54	DEXTROPROPOXYPHENE with PARACETAMOL
	A	16347	Capsule 32.5mg 325mg 20	—	—	100,434	—
	A	16444	Tablet 32.5mg 325mg 20	—	—	359,383	—
	A	16650	Tablet 32.5mg 325mg 20	—	—	19,651	—
ORIPAVINE DERIVATIVES
N02AE01	BUPRENORPHINE
	A	15207	Tablets 2mg (slow release)	1.20	MG	586	—
	P	8865N	Trans patch 5mg (release approx 5ug per hour) 2	1.20	MG	410,107	12,865,004
	P	8866P	Trans patch 10mg (release approx 10ug per hour)	1.20	MG	395,448	20,340,215
	P	8867Q	Trans patch 20mg (release approx 20ug per hour)	1.20	MG	226,826	17,965,382
OTHER OPIOIDS
N02AX02	TRAMADOL
	P	2527B	Tablet 50mg (twice daily sustained release) 20	0.30	GM	129,264	2,103,105
	P	3484J	Injection 100mg in 2mL 5	0.30	GM	15,656	223,774
	P	5232J	Capsule 50mg 20	0.30	GM	663	6,070
	P	5234L	Tablet 100mg (twice daily sustained release) 20	0.30	GM	226	3,093
	P	5236N	Tablet 200mg (twice daily sustained release) 20	0.30	GM	259	4,813
	P	8455B	Capsule 50mg 20	0.30	GM	134,910	1,249,008
	P	8523N	Tablet 100mg (twice daily sustained release) 20	0.30	GM	437,055	9,069,541
	P	8524P	Tablet 150mg (twice daily sustained release) 20	0.30	GM	214,572	6,011,786
	P	8525Q	Tablet 200mg (twice daily sustained release) 20	0.30	GM	380,246	12,667,176
	P	8582Q	Injection 100mg in 2mL 5	0.30	GM	10,582	150,680
	P	8611F	Capsule 50mg 20	0.30	GM	831,434	7,629,153
	P	8843K	Oral drops 100mg per mL 10mL	0.30	GM	3,389	78,823
	P	9199E	Tablet 100mg (once a day extended release)	0.30	GM	23,423	457,990
	P	9200F	Tablet 200mg (once a day extended release) 10	0.30	GM	25,975	750,563
	P	9201G	Tablet 300mg (once a day extended release) 10	0.30	GM	14,716	552,656
OTHER ANALGESICS AND ANTIPYRETICS
SALICYLIC ACID DERIVATIVES
N02BA01	ASPIRIN
	P	1010E	Tablet 300mg (dispersible)	3.00	GM	102,362	874,747

N02 - ANALGESICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANALGESICS OTHER ANALGESICS AND ANTIPYRETICS ANILIDES
N02BE51	METOCLOPRAMIDE and PARACETAMOL
	A	18386	Tablet 5mg/500mg 24	—	—	303	—
	A	19053	Tablet 5mg/500mg 8	—	—	2,368	—
	A	19575	Capsule 5mg/500mg 10	—	—	1,715	—
N02BE01	PARACETAMOL
	A	11515	Tablet 500mg 50	3.00	GM	1,192	—
	A	11516	Tablet 500mg 100	3.00	GM	268	—
	A	11517	Tab-sol 500mg 24	3.00	GM	214	—
	P	1746X	Tablet 500mg	3.00	GM	555,142	4,640,151
	P	1747Y	Mixture 120mg per 5mL 100mL	3.00	GM	11,511	108,256
	P	1770E	Elixir 240mg per 5mL 200mL	3.00	GM	101,256	1,290,613
	P	5196L	Tablet 500mg	3.00	GM	221	1,793
	P	5319Y	Suppositories 500mg 24	3.00	GM	1,832	103,566
	P	5320B	Suppositories 500mg 24	3.00	GM	743	44,789
	P	5343F	Tablet 665mg (modified release) 9 6	3.00	GM	1,637	27,105
	P	5344G	Tablet 665mg (modified release) 9 6	3.00	GM	439	7,121
	P	8784H	Tablet 500mg 300	3.00	GM	1,211,799	14,883,678
	P	8814X	Tablet 665mg (modified release) 1 92	3.00	GM	2,977,467	49,264,227
N02BE51	PARACETAMOL with CODEINE with DOXYLAMINE
	A	10870	Tablet 24	—	—	5,335	—
	A	12600	Tablet 20	—	—	45,772	—
	A	12932	Capsule 24	—	—	1,717	—
	A	13102	Tablet 20	—	—	159,513	—
	A	13200	Capsule 20	—	—	182	—
	A	13823	Capsule 20	—	—	1,392	—
	A	14177	Tablet 20	—	—	44,907	—
	A	14187	Tablet 20	—	—	536	—
	A	15650	Caplet 500mg-8mg-5mg	—	—	10,164	—
	A	17268	Tablet 500mg-9.6mg-5.1mg 20	—	—	4,058	—
	A	21244	Tablet 450mg 9.75mg 5mg 24	—	—	328	—
	A	21251	Tablet 450mg 9.75mg 5mg 24	—	—	212	—
N02BE51	PARACETAMOL with PROMETHAZINE with CODEINE
	A	14779	Syrup 200mL 1	—	—	3,173	—
	A	18358	Syrup 120mg-6.5mg-5mg in 5mL 100mL	—	—	2,545	—
OTHERS ANALGESICS AND ANTIPYRETICS
N02BG09	METHOXYFLURANE
	P	3489P	Liquid for inhalation 999.9mg per g, 3mL (with inhaler)	—	—	9,585	429,222
ANTIMIGRAINE PREPARATIONS
ERGOT ALKALOIDS
N02CA01	DIHYDROERGOTAMINE
	P	1323P	Injection 1mg in 1mL	4.00	MG	1,522	38,195
	P	3460D	Injection 1mg in 1mL	4.00	MG	4,757	81,095

N02 - ANALGESICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANALGESICS ANTIMIGRAINE PREPARATIONS
N02CA52	ERGOTAMINE TARTRATE with CAFFEINE
	A	18569	Suppositories 2mg-100mg 5	—	—	18,463	—
N02CA52	ERGOTAMINE with CAFFEINE
	A	13550	Tablet 1mg-100mg 20	—	—	489	—
N02CA04	METHYSERGIDE
	P	2826R	Tablet 1mg	4.00	MG	7,314	341,470
SELECTIVE 5HT RECEPTOR AGONISTS
N02CC06	ELETRIPTAN
	P	5290K	Tablet 40mg (as hydrobromide) 4	40.00	MG	975	23,735
	P	5291L	Tablet 80mg (as hydrobromide) 4	40.00	MG	384	9,123
N02CC02	NARATRIPTAN
	P	8298R	Tablet 2.5mg (as hydrochloride) 4 (2 upto Feb06)	2.50	MG	86,841	2,239,666
	P	9734H	Tablet 2.5mg (as hydrochloride) 4	2.50	MG	6,251	177,129
N02CC04	RIZATRIPTAN
	P	9313E	Wafer 10mg (as benzoate)	10.00	MG	36,209	902,366
N02CC01	SUMATRIPTAN
	A	14181	Tablet 100mg	50.00	MG	14,187	—
	A	15987	Nasal Spray 10mg per dose 2	20.00	MG	1,317	—
	A	16720	Injection 6mg in 0.5mL refill	6.00	MG	1,405	—
	A	16730	Injection 6mg in 0.5mL	6.00	MG	119	—
	A	19640	Tablet 100mg 2	50.00	MG	279	—
	A	19998	Tablet 100mg 2	50.00	MG	208	—
	A	20306	Tablet 100mg 4	50.00	MG	528	—
	A	20307	Tablet 50mg 2	50.00	MG	179	—
	P	8144P	Tablet 50mg (base) 4 (2 upto Feb06)	50.00	MG	363,768	9,008,650
	P	8341B	Nasal Spray 20mg per dose 2	20.00	MG	84,748	1,652,744
	P	8885P	Tablet (fast disintegrating) 50mg (as succinate) 4	50.00	MG	40,801	1,006,275
N02CC03	ZOLMITRIPTAN
	P	8266C	Tablet 2.5mg 4 (2 upto Feb06)	2.50	MG	127,772	3,291,430
	P	9736K	Tablet 2.5mg 4	2.50	MG	13,795	381,706
OTHER ANTIMIGRAINE PREPARATIONS
N02CX01	PIZOTIFEN MALATE
	P	3074T	Tablet 500ug (base)	1.50	MG	130,754	2,963,940

N03 - ANTIEPILEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANTIEPILEPTICS ANTIEPILEPTICS BARBITURATES AND DERIVATIVES
N03AA02	PHENOBARBITONE
	P	1850J	Tablet 30mg	0.10	GM	14,762	227,503
	P	1853M	Injection 200mg in 1mL	0.10	GM	130	7,457
	A	18751	Elixir 15mg/5mL 100mL	100.00	MG	174	—
N03AA03	PRIMIDONE
	P	1939C	Tablet 250mg	1.25	GM	15,853	1,319,272
HYDANTOIN DERIVATIVES
N03AB02	PHENYTOIN
	P	1249R	Tablet 50mg	0.30	GM	6,587	223,499
	P	1873N	Capsule 30mg	0.30	GM	19,943	577,722
	P	1874P	Capsule 100mg	0.30	GM	144,376	4,324,250
	P	2692Q	Paediatric oral suspension 30mg per 5mL 500mL	0.30	GM	9,879	304,899
SUCCINIMIDE DERIVATIVES
N03AD01	ETHOSUXIMIDE
	P	1413J	Capsule 250mg	1.25	GM	3,011	163,120
	P	1414K	Paediatric syrup 250mg per 5mL 250mL	1.25	GM	2,960	96,233
BENZODIAZEPINE DERIVATIVES
N03AE01	CLONAZEPAM
	P	1805B	Tablet 500ug	8.00	MG	33,662	673,085
	P	1806C	Tablet 2mg	8.00	MG	30,340	966,507
	P	1807D	Injection 1mg in 2mL (set containing solution)	8.00	MG	2,478	61,296
	P	1808E	Paediatric oral drops 2.5mg in 1mL 10mL	8.00	MG	5,548	94,847
	P	3478C	Oral liquid 2.5mg per mL 10mL	8.00	MG	1,620	17,385
	P	5337X	Tablet 500ug	8.00	MG	30,895	511,747
	P	5338Y	Tablet 2mg	8.00	MG	5,993	150,947
	P	5339B	Oral liquid 2.5mg per mL 10mL	8.00	MG	8,545	134,500
	P	5340C	Tablet 500ug	8.00	MG	15,328	243,452
	P	5341D	Tablet 2mg	8.00	MG	5,945	158,457
	P	5342E	Oral liquid 2.5mg per mL 10mL	8.00	MG	815	13,011
CARBOXAMIDE DERIVATIVES
N03AF01	CARBAMAZEPINE
	P	2419H	Tablet 200mg	1.00	GM	121,613	3,665,244
	P	2422L	Tablet 100mg	1.00	GM	52,591	998,697
	P	2426Q	Tablet 200mg (controlled release)	1.00	GM	73,759	2,257,158
	P	2427R	Oral suspension 100mg per 5mL 300mL	1.00	GM	24,023	695,037
	P	2431Y	Tablet 400mg (controlled release)	1.00	GM	54,776	2,785,728
	P	5039F	Tablet 100mg	1.00	GM	111	1,898
N03AF02	OXCARBAZEPINE
	P	8584T	Tablet 150mg 100	1.00	GM	1,903	144,226
	P	8585W	Tablet 300mg 100	1.00	GM	7,140	903,734
	P	8586X	Tablet 600mg 100	1.00	GM	4,746	945,585
	P	8588B	Oral suspension 60mg per mL 250mL	1.00	GM	1,136	162,166

N03 - ANTIEPILEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANTIEPILEPTICS ANTIEPILEPTICS FATTY ACID DERIVATIVES
N03AG01	SODIUM VALPROATE
	P	2289L	Tablet 200mg (enteric coated) 200	1.50	GM	278,359	9,097,697
	P	2290M	Tablet 500mg (enteric coated) 200	1.50	GM	321,778	18,030,741
	P	2293Q	Oral liquid 200mg per 5mL 300 mL	1.50	GM	56,709	2,216,697
	P	2294R	Crushable tablet 100mg	1.50	GM	59,176	2,001,298
	P	2295T	Syrup 200mg per 5mL 300mL	1.50	GM	16,285	638,991
N03AG06	TIAGABINE
	P	8221Q	Tablet 5mg (base)	30.00	MG	745	64,641
	P	8222R	Tablet 10mg (base)	30.00	MG	915	149,484
	P	8223T	Tablet 15mg (base)	30.00	MG	339	66,743
N03AG04	VIGABATRIN
	P	2667J	Tablet 500mg 120	2.00	GM	7,749	1,068,355
	P	2668K	Oral powder sachet 500mg	2.00	GM	2,271	227,886
OTHER ANTIEPILEPTICS
N03AX12	GABAPENTIN
	P	1834M	Capsule 300mg 100	1.80	GM	78,836	5,530,885
	P	1835N	Capsule 400mg 100	1.80	GM	19,238	1,976,113
	P	4591P	Capsule 100mg 100	1.80	GM	6,023	163,527
	P	4592Q	Capsule 300mg 100	1.80	GM	12,350	889,318
	P	4593R	Capsule 400mg 100	1.80	GM	1,539	140,279
	P	4594T	Tablet 600mg 100	1.80	GM	1,413	210,799
	P	4595W	Tablet 800mg 100	1.80	GM	487	86,688
	P	8389M	Tablet 800mg 100	1.80	GM	11,675	2,173,171
	P	8505P	Capsule 100mg 100	1.80	GM	31,031	767,491
	P	8559L	Tablet 600mg 100	1.80	GM	16,968	2,353,284
N03AX18	LACOSAMIDE
	P	9333F	Tablet 50mg 14	0.30	GM	1,370	149,098
	P	9335H	Tablet 100mg 56	0.30	GM	2,729	565,237
	P	9337K	Tablet 150mg 56	0.30	GM	414	112,857
	P	9338L	Tablet 200mg 56	0.30	GM	779	277,512
N03AX09	LAMOTRIGINE
	P	2848X	Tablet 25mg	0.30	GM	42,990	1,498,572
	P	2849Y	Tablet 50mg	0.30	GM	78,658	3,871,724
	P	2850B	Tablet 100mg	0.30	GM	130,861	9,925,032
	P	2851C	Tablet 200mg	0.30	GM	94,744	11,386,301
	P	8063J	Tablet 5mg	0.30	GM	4,522	105,337
N03AX14	LEVETIRACETAM
	P	8654L	Tablet 250mg 60	1.50	GM	33,414	2,212,267
	P	8655M	Tablet 500mg 60	1.50	GM	99,755	11,129,768
	P	8656N	Tablet 1gm 60	1.50	GM	51,349	8,517,854
	P	9169N	Oral solution 100mg per mL 300mL	1.50	GM	6,086	793,991
	P	9708Y	Tablet 250mg 60	1.50	GM	5,054	420,336

N03 - ANTIEPILEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANTIEPILEPTICS ANTIEPILEPTICS
	P	9709B	Tablet 500mg 60	1.50	GM	16,947	2,362,552
	P	9710C	Tablet 1gm 60	1.50	GM	10,430	2,092,063
N03AX16	PREGABALIN
	P	4320J	Capsules 25mg 56	0.30	GM	9,199	386,172
	P	4322L	Capsules 75mg 56	0.30	GM	110,987	10,077,848
	P	4323M	Capsules 150mg 56	0.30	GM	58,104	7,652,194
	P	4324N	Capsules 300mg 56	0.30	GM	19,844	3,776,264
N03AX03	SULTHIAME
	P	2099L	Tablet 50mg	0.40	GM	1,232	57,166
	P	2100M	Tablet 200mg	0.40	GM	1,524	150,217
N03AX11	TOPIRAMATE
	P	8163P	Tablet 25mg	0.30	GM	63,740	2,910,157
	P	8164Q	Tablet 50mg	0.30	GM	76,538	5,225,488
	P	8165R	Tablet 100mg	0.30	GM	44,458	4,523,372
	P	8166T	Tablet 200mg	0.30	GM	22,296	3,926,847
	P	8371N	Capsule 15mg	0.30	GM	1,497	74,853
	P	8372P	Capsule 25mg	0.30	GM	1,863	94,867
	P	8520K	Capsule 50mg	0.30	GM	2,371	215,502

N04 - ANTI-PARKINSON DRUGS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANTI-PARKINSON DRUGS ANTICHOLINERGIC AGENTS TERTIARY AMINES WITH CARBON CHAIN
N04AA01	BENZHEXOL HYDROCHLORIDE
	P	1109J	Tablet 2mg	10.00	MG	11,406	172,439
	P	1110K	Tablet 5mg	10.00	MG	4,705	102,709
N04AA02	BIPERIDEN HYDROCHLORIDE
	P	2544X	Tablet 2mg	10.00	MG	12,561	257,068
ETHERS OF TROPINE OR TROPINE DERIVATIVES
N04AC01	BENZTROPINE MESYLATE
	P	2362H	Tablet 2mg 60	2.00	MG	58,867	745,508
	P	3038X	Injection 2mg in 2mL	2.00	MG	896	92,181
	P	3457Y	Injection 2mg in 2mL	2.00	MG	10,291	766,183
DOPAMINERGIC AGENTS
DOPA AND DOPA DERIVATIVES
N04BA02	LEVODOPA with BENSERAZIDE
	P	2225D	Capsule 100mg-25mg	0.60	GM	37,625	1,530,142
	P	2226E	Capsule 200mg-50mg	0.60	GM	20,070	1,071,671
	P	2227F	Capsule 50mg-12.5mg	0.60	GM	22,570	527,555
	P	2228G	Tablet 200mg-50mg	0.60	GM	43,010	2,372,405
	P	2229H	Tablet 100mg-25mg	0.60	GM	61,539	2,582,720
	P	2231K	Capsule 100mg-25mg (sustained release)	0.60	GM	19,525	894,437
	P	8218M	Dispersible tablet 50mg-12.5mg	0.60	GM	7,366	183,307
	P	8219N	Dispersible tablet 100mg-12.5mg	0.60	GM	9,013	408,341
N04BA02	LEVODOPA with CARBIDOPA
	P	1242J	Tablet 100mg-25mg	0.60	GM	198,324	8,578,670
	P	1245M	Tablet 250mg-25mg	0.60	GM	47,054	2,280,992
	P	1255C	Tablet 200mg-50mg 100	0.60	GM	15,523	1,132,194
N04BA03	LEVODOPA with CARBIDOPA and ENTACAPONE
	P	9344T	Tablet 75mg-18.75mg-200mg 200	0.45	GM	330	107,238
	P	9345W	Tablet 125mg-31.25mg-200mg 200	0.45	GM	847	295,614
N04BA03	LEVODOPA,DECARBOXYLASE INHIBITOR and COMT INHIBITOR
	P	8797B	Tablet 50mg-12.5mg-200mg	0.45	GM	2,053	636,415
	P	8798C	Tablet 100mg-25mg-200mg	0.45	GM	13,562	4,581,579
	P	8799D	Tablet 150mg-37.5mg-200mg	0.45	GM	12,351	4,555,903
	P	9292C	Tablet 200mg-50mg-200mg 200	0.45	GM	5,977	2,346,258
ADAMANTANE DERIVATIVES
N04BB01	AMANTADINE HYDROCHLORIDE
	P	3016R	Capsule 100mg	0.20	GM	15,224	673,854
DOPAMINE AGONISTS
N04BC07	APOMORPHINE
	P	9607P	Injection 20mg in 2mL 5	20.00	MG	413	863,458
	P	9640J	Injection 50mg in 5mL 5	20.00	MG	318	636,610
N04BC01	BROMOCRIPTINE MESYLATE
	P	1443Y	Capsule 2.5mg (base)	40.00	MG	8,039	288,726

N04 - ANTI-PARKINSON DRUGS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM ANTI-PARKINSON DRUGS DOPAMINERGIC AGENTS
	P	1445C	Capsule 10mg	40.00	MG	690	112,024
	P	1446D	Capsule 5mg	40.00	MG	3,110	174,264
N04BC06	CABERGOLINE
	P	8393R	Tablet 1mg 30	3.00	MG	15,174	1,005,917
	P	8394T	Tablet 2mg 30	3.00	MG	15,607	1,502,600
N04BC02	PERGOLIDE
	P	2808T	Tablet 50ug (base)	3.00	MG	529	34,663
	P	2809W	Tablet 250ug (base)	3.00	MG	2,039	140,700
	P	2810X	Tablet 1mg (base)	3.00	MG	995	245,976
N04BC05	PRAMIPEXOLE
	P	3418X	Tablet 0.375mg	2.50	MG	1,389	31,054
	P	3419Y	Tablet 0.75mg 30	2.50	MG	2,388	90,902
	P	3420B	Tablet 1.5mg 30	2.50	MG	2,362	156,993
	P	3421C	Tablet 3mg 30	2.50	MG	1,384	190,254
	P	3422D	Tablet 4.5mg (extended release) 30	2.50	MG	702	142,748
	P	9151P	Tablet 125ug 30	2.50	MG	6,407	88,766
	P	9152Q	Tablet 250ug 100	2.50	MG	44,208	1,909,857
	P	9153R	Tablet 1mg 100	2.50	MG	28,669	4,454,846
	P	9393J	Tablet 125ug 30	2.50	MG	38,333	450,615
	P	9394K	Tablet 250ug 100	2.50	MG	19,266	793,161
N04BC04	ROPINIROLE
	A	18889	Tablet 0.5mg 28	6.00	MG	6,346	—
	A	18890	Tablet 2mg 28	6.00	MG	1,573	—
MONOAMINE OXIDASE TYPE B INHIBITORS
N04BD01	SELEGILINE HYDROCHLORIDE
	P	1973W	Tablet 5mg 100	5.00	MG	5,957	322,907
OTHER DOPAMINERGIC AGENTS
N04BX02	ENTACAPONE
	P	8367J	Tablet 200mg	1.00	GM	14,586	4,104,786

N05 - PSYCHOLEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOLEPTICS ANTIPSYCHOTICS PHENOTHIAZINE WITH DIMETHYLAMINOPROPYL GROUP
N05AA01	CHLORPROMAZINE HYDROCHLORIDE
	P	1195X	Injection 50mg in 2mL	0.10	GM	646	11,734
	P	1196Y	Tablet 10mg	0.30	GM	9,040	94,733
	P	1197B	Tablet 25mg	0.30	GM	36,568	406,727
	P	1199D	Tablet 100mg	0.30	GM	25,288	445,761
	P	1201F	Mixture 25mg per 5mL 100mL	0.30	GM	5,334	94,671
	P	3455W	Injection 50mg in 2mL	0.10	GM	3,300	60,883
PHENOTHIAZINE WITH PIPERAZINE STRUCTURE
N05AB02	FLUPHENAZINE DECANOATE
	P	1001Q	Injection 50mg in 2mL	1.00	MG	3,810	143,346
	P	1046C	Injection 12.5mg in 0.5mL	1.00	MG	1,978	37,972
	P	3098C	Injection 25mg in 1mL	1.00	MG	3,954	103,812
N05AB04	PROCHLORPERAZINE
	A	21180	Suppositories 5mg 10	100.00	MG	661	—
	P	2369Q	Injection 12.5mg in 1mL	50.00	MG	5,786	109,891
	P	2893G	Tablet 5mg	100.00	MG	799,671	8,333,104
	P	2895J	Suppositories 25mg 5	100.00	MG	18,654	455,172
	P	3477B	Injection 12.5mg in 1mL	50.00	MG	9,939	166,525
	P	5205Y	Tablet 5mg	100.00	MG	147	1,435
N05AB06	TRIFLUOPERAZINE HYDROCHLORIDE
	P	2185B	Tablet 1mg (base)	20.00	MG	12,058	160,462
	P	2186C	Tablet 5mg (base)	20.00	MG	13,489	193,604
	P	2386N	Tablet 2mg (base)	20.00	MG	7,413	101,081
PHENOTHIAZINE WITH PIPERIDINE STRUCTURE
N05AC01	PERICYAZINE
	P	3052P	Tablet 2.5mg	50.00	MG	33,302	346,980
	P	3053Q	Tablet 10mg	50.00	MG	15,387	223,266
BUTYROPHENONE DERIVATIVES
N05AD01	HALOPERIDOL
	P	2761H	Tablet 500ug 100	8.00	MG	43,914	439,992
	P	2763K	Oral liquid 2mg per mL 100 mL	8.00	MG	1,640	28,622
	P	2765M	I.M. injection equivalent to 50mg haloperidol	3.30	MG	2,166	57,588
	P	2766N	I.M. injection equivalent to 150mg haloperidol	3.30	MG	1,760	80,760
	P	2767P	Tablet 1.5mg	8.00	MG	13,037	136,971
	P	2768Q	Injection 5mg in 1mL	8.00	MG	9,055	213,596
	P	2770T	Tablet 5mg	8.00	MG	18,057	204,576
	P	3456X	Injection 5mg in 1mL	8.00	MG	3,981	87,737
INDOLE DERIVATIVES
N05AE04	ZIPRASIDONE
	A	19954	Capsule 20mg 60	80.00	MG	25,691	—
	P	9070J	Capsule 20mg 60	80.00	MG	6,045	564,009
	P	9071K	Capsule 40mg 60	80.00	MG	11,009	2,000,410

N05 - PSYCHOLEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOLEPTICS ANTIPSYCHOTICS
	P	9072L	Capsule 60mg 60	80.00	MG	4,847	1,276,607
	P	9073M	Capsule 80mg 60	80.00	MG	13,213	4,578,287
THIOXANTHENE DERIVATIVES
N05AF01	FLUPENTHIXOL
	P	2255Q	Injection oily I.M. 20mg in 1mL	4.00	MG	4,489	85,535
	P	2256R	Injection oily I.M. 40mg in 1mL	4.00	MG	4,101	106,911
	P	2257T	Injection oily I.M. 100mg in 1mL	4.00	MG	5,272	233,261
N05AF05	ZUCLOPENTHIXOL
	A	15616	Tablet 10mg 100	30.00	MG	336	—
	P	8097E	Oily I.M. injection 200mg in 1mL 5	15.00	MG	27,592	694,313
DIPHENYLBUTYLPIPERIDINE DERIVATIVES
N05AG02	PIMOZIDE
	A	11421	Tablet 2mg 50	4.00	MG	197	—
DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES
N05AH02	CLOZAPINE
	P	6101D	Tablet 25mg 100	0.30	GM	6,255	365,159
	P	6102E	Tablet 100mg 100	0.30	GM	29,752	9,166,101
	P	6417R	Tablet 50mg 100	0.30	GM	8,309	625,615
	P	6418T	Tablet 200mg 100	0.30	GM	18,109	6,870,141
N05AH03	OLANZAPINE
	P	8170B	Tablet 2.5mg 30	10.00	MG	164,970	9,544,358
	P	8185T	Tablet 5mg 30	10.00	MG	265,840	29,500,577
	P	8186W	Tablet 7.5mg 30	10.00	MG	65,452	11,878,802
	P	8187X	Tablet 10mg 30	10.00	MG	342,921	94,996,540
	P	8433W	Wafer 5mg 28	10.00	MG	57,019	6,406,186
	P	8434X	Wafer 10mg 28	10.00	MG	70,564	19,811,546
	P	9294E	Powder for injection 210mg (as pamoate monohydrate) with diluent 2	10.00	MG	139	67,473
	P	9295F	Powder for injection 300mg (as pamoate monohydrate) with diluent 2	10.00	MG	230	168,142
	P	9303P	Powder for injection 405mg (as pamoate monohydrate) with diluent 2	10.00	MG	140	70,236
N05AH04	QUETIAPINE
	P	8456C	Tablet 25mg (base) 60	0.40	GM	248,642	14,371,132
	P	8457D	Tablet 100mg (base) 90	0.40	GM	145,631	20,458,119
	P	8458E	Tablet 200mg (base) 60	0.40	GM	124,501	27,449,648
	P	8580N	Tablet 300mg (base) 60	0.40	GM	91,964	28,457,028
	P	9202H	Tablet (modified release) equivalent to 50mg	0.40	GM	37,886	3,953,725
	P	9203J	Tablet (modified release) equivalent to 200mg 60	0.40	GM	19,761	3,848,052
	P	9204K	Tablet (modified release) equivalent to 300mg 60	0.40	GM	22,025	6,255,384
	P	9205L	Tablet (modified release) equivalent to 400mg 60	0.40	GM	18,778	6,972,563
BENZAMIDES
N05AL05	AMISULPRIDE
	P	8594H	Tablet 100mg 30	0.40	GM	21,236	876,178
	P	8595J	Tablet 200mg 60	0.40	GM	29,589	3,746,137
	P	8596K	Tablet 400mg 60	0.40	GM	33,125	7,441,879

N05 - PSYCHOLEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOLEPTICS ANTIPSYCHOTICS
	P	8736T	Oral solution 100mg per mL 60mL 2	0.40	GM	303	52,476
LITHIUM
N05AN01	LITHIUM CARBONATE
	P	3059B	Tablet 250mg 200	889.00	MG	99,638	1,672,496
	P	8290H	Tablet 450mg (slow release) 200	889.00	MG	40,666	1,343,160
OTHER ANTIPSYCHOTICS
N05AX12	ARIPIPRAZOLE
	A	19165	Tablet 5mg 30	15.00	MG	242	—
	P	8717T	Tablet 10mg 30	15.00	MG	47,325	7,547,093
	P	8718W	Tablet 15mg 30	15.00	MG	30,661	7,029,255
	P	8719X	Tablet 20mg 30	15.00	MG	21,326	5,871,145
	P	8720Y	Tablet 30mg 30	15.00	MG	25,856	8,535,264
N05AX13	PALIPERIDONE
	P	9140C	Tablet 3mg (prolonged release) 28	6.00	MG	9,830	1,657,753
	P	9141D	Tablet 6mg (prolonged release) 28	6.00	MG	14,028	2,683,892
	P	9142E	Tablet 9mg (prolonged release) 28	6.00	MG	4,948	1,127,061
N05AX08	RISPERIDONE
	P	3169T	Tablet 1mg	5.00	MG	77,444	4,167,340
	P	3170W	Tablet 2mg	5.00	MG	55,009	6,279,971
	P	3171X	Tablet 3mg	5.00	MG	33,308	5,595,553
	P	3172Y	Tablet 4mg	5.00	MG	28,024	6,313,495
	P	8100H	Oral solution 1mg per mL 100mL	5.00	MG	5,426	674,390
	P	8780D	Pdr for I.M. injection 25mg/2mL diluent syringe	2.70	MG	42,998	13,291,837
	P	8781E	Pdr for I.M. injection 37.5mg/2mL diluent syringe	2.70	MG	42,275	17,397,951
	P	8782F	Pdr for I.M. injection 50mg/2mL diluent syringe	2.70	MG	54,947	26,716,152
	P	8787L	Tablet 0.5mg 60	5.00	MG	100,882	3,154,390
	P	8788M	Tablet 0.5mg (orally disintegrating) 56	5.00	MG	22,667	775,842
	P	8789N	Tablet 1mg 60	5.00	MG	66,976	3,581,896
	P	8790P	Tablet 1mg (orally disintegrating) 56	5.00	MG	8,688	516,342
	P	8792R	Tablet 1mg (orally disintegrating) 56	5.00	MG	7,309	427,300
	P	8794W	Tablet 2mg (orally disintegrating) 56	5.00	MG	6,322	678,941
	P	8869T	Tablet 0.5mg 60	5.00	MG	70,968	2,210,279
	P	8870W	Tablet 0.5mg (orally disintegrating) 56	5.00	MG	12,072	408,197
	P	9075P	Tablet 3mg (orally disintegrating) 56	5.00	MG	2,810	408,360
	P	9076Q	Tablet 4mg (orally disintegrating) 56	5.00	MG	2,096	396,913
	P	9079W	Tablet 2mg 60	5.00	MG	22,515	2,494,530
	P	9080X	Tablet 2mg (orally disintegrating) 56	5.00	MG	2,208	239,018
	P	9293D	Oral solution 1mg per mL 100mL 1	5.00	MG	6,768	816,262
ANXIOLYTICS
BENZODIAZEPINE DERIVATIVES
N05BA12	ALPRAZOLAM
	P	2130D	Tablet 250ug	1.00	MG	86,308	888,055
	P	2131E	Tablet 500ug	1.00	MG	186,500	2,435,024

N05 - PSYCHOLEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOLEPTICS ANXIOLYTICS
	P	2132F	Tablet 1mg	1.00	MG	222,591	4,130,974
	P	8118G	Tablet 2mg	1.00	MG	191,227	4,916,331
N05BA08	BROMAZEPAM
	P	4150K	Tablet 3mg	10.00	MG	12,514	339,909
	P	4151L	Tablet 6mg	10.00	MG	22,637	741,150
N05BA09	CLOBAZAM
	A	10898	Tablet 10mg 50	20.00	MG	23,491	—
N05BA01	DIAZEPAM
	A	15450	Elixir 0.1% 100mL	10.00	MG	1,045	—
	A	20925	Tablet 2mg 50	10.00	MG	3,027	—
	A	20929	Tablet 5mg 50	10.00	MG	2,304	—
	P	2558P	Injection 10mg in 2mL	10.00	MG	4,607	61,958
	P	3161J	Tablet 2mg	10.00	MG	251,865	1,958,602
	P	3162K	Tablet 5mg	10.00	MG	1,956,315	15,498,724
	P	3458B	Injection 10mg in 2mL	10.00	MG	11,919	146,437
	P	5071X	Tablet 2mg	10.00	MG	352	2,648
	P	5072Y	Tablet 5mg	10.00	MG	3,769	28,318
	P	5355W	Tablet 2mg 50	10.00	MG	569	4,942
	P	5356X	Tablet 5mg 50	10.00	MG	2,620	24,253
	P	5357Y	Tablet 2mg 50	10.00	MG	133	781
	P	5358B	Tablet 5mg 50	10.00	MG	1,968	17,783
N05BA06	LORAZEPAM
	A	13807	Tablet 1mg 50	2.50	MG	83,268	—
	A	13808	Tablet 2.5mg 50	2.50	MG	33,184	—
N05BA04	OXAZEPAM
	P	3132W	Tablet 15mg	50.00	MG	243,649	1,850,496
	P	3133X	Tablet 30mg	50.00	MG	995,625	7,745,354
	P	3134Y	Tablet 15mg	50.00	MG	10,656	98,863
	P	3135B	Tablet 30mg	50.00	MG	11,876	113,471
	P	5371Q	Tablet 15mg 50	50.00	MG	413	3,720
	P	5372R	Tablet 30mg 50	50.00	MG	976	9,287
	P	5374W	Tablet 30mg 50	50.00	MG	940	10,297
AZASPIRODECANEDIONE DERIVATIVES
N05BE01	BUSPIRONE HYDROCHLORIDE
	P	4144D	Tablet 5mg 50	30.00	MG	1,554	78,954
	P	4145E	Tablet 10mg 50	30.00	MG	2,034	183,733
HYPNOTICS AND SEDATIVES
ALDEHYDES AND DERIVATIVES
N05CC01	CHLORAL HYDRATE
	A	18744	Syrup 1g/10mL 200mL	1.00	GM	204	—
BENZODIAZEPINE DERIVATIVES
N05CD03	FLUNITRAZEPAM
	P	4216X	Tablet 1mg 30	1.00	MG	38,382	682,333

N05 - PSYCHOLEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOLEPTICS HYPNOTICS AND SEDATIVES
N05CD08	MIDAZOLAM
	A	11021	Ampoule 15mg/3mL 5	15.00	MG	393	—
	A	12645	Ampoule 5mg/mL 10	15.00	MG	17,249	—
	A	13771	Ampoule 5mg/mL 10	15.00	MG	525	—
	A	17973	Ampoule 5mg/mL 5	15.00	MG	175	—
	A	18505	Ampoule 5mg/mL 10	15.00	MG	3,277	—
N05CD02	NITRAZEPAM
	P	2723H	Tablet 5mg 25	5.00	MG	526,612	4,154,159
	P	2732T	Tablet 5mg 50	5.00	MG	10,620	105,797
	P	5359C	Tablet 5mg 50	5.00	MG	823	7,931
	P	5360D	Tablet 5mg 50	5.00	MG	449	4,381
N05CD07	TEMAZEPAM
	P	2088X	Tablet 10mg	20.00	MG	62,352	570,108
	P	2089Y	Tablet 10mg 25	20.00	MG	2,498,377	19,253,388
	P	5221T	Tablet 10mg	20.00	MG	1,177	8,916
	P	5375X	Tablet 10mg 50	20.00	MG	4,758	43,702
	P	5376Y	Tablet 10mg 50	20.00	MG	1,074	10,143
N05CD05	TRIAZOLAM
	A	13374	Tablet 0.125mg 50	0.25	MG	6,761	—
BENZODIAZEPINE RELATED DRUGS
N05CF02	ZOLPIDEM
	A	16809	Tablet 10mg 7	10.00	MG	9,841	—
	A	17644	Tablet 10mg 20	10.00	MG	926	—
	A	19763	Tablet 6.25mg 21	10.00	MG	223	—
	A	19765	Tablet 12.5mg 21	10.00	MG	397	—
	A	19797	Tablet 10mg 7	10.00	MG	264	—
	A	19803	Tablet 10mg 7	10.00	MG	16,444	—
	A	19817	Tablet 10mg 7	10.00	MG	2,198	—
	A	20114	Tablet 10mg 20	10.00	MG	233	—
	A	20115	Tablet 10mg 7	10.00	MG	126	—
	A	20286	Tablet 10mg 14	10.00	MG	10,703	—
	A	20288	Tablet 10mg 14	10.00	MG	29,099	—
	A	20289	Tablet 10mg 14	10.00	MG	115,292	—
	A	20290	Tablet controlled release 6.25mg 14	10.00	MG	9,332	—
	A	20291	Tablet controlled release 12.5mg 14	10.00	MG	86,838	—
	A	20305	Tablet 10mg 14	10.00	MG	114,493	—
	A	20311	Tablet 10mg 14	10.00	MG	7,059	—
	A	20393	Tablet 10mg 14	10.00	MG	7,373	—
	A	20454	Tablet 10mg 14	10.00	MG	525	—
	A	20466	Tablet 10mg 14	10.00	MG	11,864	—
N05CF01	ZOPICLONE
	A	14925	Tablet 7.5mg 10	7.50	MG	14,884	—
	P	4522B	Tablet 7.5mg	7.50	MG	119,383	3,066,474
N05CH01 MELATONIN
	A	21037	Tablet prolonged release 2mg 21	2.00	MG	40,568	—

N06 - PSYCHOANALEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOANALEPTICS ANTIDEPRESSANTS NON SELECTIVE MONOAMINE REUPTAKE INHIBITORS
N06AA09	AMITRIPTYLINE HYDROCHLORIDE
	P	2417F	Tablet 10mg 50	75.00	MG	505,287	4,271,014
	P	2418G	Tablet 25mg 50	75.00	MG	568,927	4,911,238
	P	2429W	Tablet 50mg 50	75.00	MG	459,281	4,260,622
N06AA04	CLOMIPRAMINE HYDROCHLORIDE
	P	1561E	Tablet 25mg 50	100.00	MG	62,760	2,049,040
N06AA16	DOTHIEPIN HYDROCHLORIDE
	P	1357K	Capsule 25mg 50	150.00	MG	211,958	1,928,069
	P	1358L	Tablet 75mg 50	150.00	MG	305,780	3,064,651
N06AA12	DOXEPIN HYDROCHLORIDE
	P	1011F	Capsule 10mg (base) 50	100.00	MG	62,138	559,893
	P	1012G	Tablet 50mg (base) 50	100.00	MG	121,219	1,278,971
	P	1013H	Capsule 25mg (base) 50	100.00	MG	131,720	1,295,562
N06AA02	IMIPRAMINE HYDROCHLORIDE
	P	2420J	Tablet 10mg 50	100.00	MG	34,191	296,203
	P	2421K	Tablet 25mg 50	100.00	MG	97,508	955,516
N06AA10	NORTRIPTYLINE HYDROCHLORIDE
	P	2522R	Tablet 10mg (base) 50	75.00	MG	25,633	358,533
	P	2523T	Tablet 25mg (base) 50	75.00	MG	75,151	1,546,062
N06AA06	TRIMIPRAMINE MALEATE
	A	16468	Capsule 50mg 50	150.00	MG	7,415	—
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
N06AB04	CITALOPRAM
	P	8220P	Tablet 20mg (base) 28	20.00	MG	1,379,220	38,980,953
	P	8702B	Tablet 10mg (base) 28	20.00	MG	55,773	970,520
	P	8703C	Tablet 40mg (base) 28	20.00	MG	148,356	5,341,944
N06AB10	ESCITALOPRAM
	P	8700X	Tablet 10mg (base) 28	10.00	MG	1,121,864	33,423,536
	P	8701Y	Tablet 20mg (base) 28	10.00	MG	910,753	30,895,540
	P	8849R	Oral solution 10mg (base) per mL 28mL	10.00	MG	4,944	187,392
	P	9432K	Tablet 10mg (base) 28	10.00	MG	10,751	336,899
	P	9433L	Tablet 20mg (base) 28	10.00	MG	8,885	320,217
N06AB03	FLUOXETINE HYDROCHLORIDE
	P	1434L	Capsule 20mg (base) 28	20.00	MG	914,483	27,135,877
	P	8270G	Tablet 20mg (base) (dispersible) 28	20.00	MG	271,856	7,307,121
N06AB08	FLUVOXAMINE
	P	8174F	Tablet 100mg 30	0.10	GM	288,530	11,123,316
	P	8512B	Tablet 50mg 30	0.10	GM	121,189	2,642,857
N06AB05	PAROXETINE
	P	2242B	Tablet 20mg (base) 30	20.00	MG	983,387	32,083,062
	P	9197C	Tablet 20mg (as mesilate) 30	20.00	MG	4,909	130,128
N06AB06	SERTRALINE

N06 - PSYCHOANALEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOANALEPTICS ANTIDEPRESSANTS
	P	2236Q	Tablet 50mg (base) 30	50.00	MG	1,268,892	32,541,096
	P	2237R	Tablet 100mg (base) 30	50.00	MG	1,340,918	40,230,344
	P	8836C	Tablet 50mg (base) 30	50.00	MG	55,923	1,431,970
	P	8837D	Tablet 100mg (base) 30	50.00	MG	68,592	1,993,477
MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE
N06AF03	PHENELZINE SULPHATE
	P	2856H	Tablet 15mg (base) 100	60.00	MG	7,096	939,989
N06AF04	TRANYLCYPROMINE SULPHATE
	P	2444P	Tablet 10mg (base) 50	10.00	MG	17,669	1,210,596
MONOAMINE OXIDASE TYPE A INHIBITORS
N06AG02	MOCLOBEMIDE
	P	1900B	Tablet 150mg 60	0.30	GM	41,527	795,289
	P	8003F	Tablet 300mg 60	0.30	GM	97,991	3,302,823
OTHER ANTIDEPRESSANTS
N06AX22	AGOMELATINE
	A	21346	Tablet 25mg 28	25.00	MG	2,811	—
N06AX12	BUPROPION
	P	8465M	Tablet 150mg (sustained release)	0.30	GM	12,997	983,983
	P	8710K	Tablet 150mg (sustained release) 90	0.30	GM	9,538	1,556,411
N06AX23	DESVENLAFAXINE
	P	9366Y	Tablet 50mg (base) (extended release) 28	—	—	480,717	21,424,892
	P	9367B	Tablet 100mg (base) (extended release) 28	—	—	283,685	16,184,227
N06AX21	DULOXETINE
	P	9155W	Capsule 30mg 28	60.00	MG	152,397	6,440,332
	P	9156X	Capsule 60mg 28	60.00	MG	596,303	32,740,379
N06AX03	MIANSERIN HYDROCHLORIDE
	P	1627P	Tablet 10mg 50	60.00	MG	18,651	301,241
	P	1628Q	Tablet 20mg 50	60.00	MG	39,682	1,452,990
N06AX11	MIRTAZAPINE
	P	8513C	Tablet 30mg 30	30.00	MG	875,080	27,180,395
	P	8855C	Tablet 15mg (orally disintegrating) 30	30.00	MG	108,672	2,221,022
	P	8856D	Tablet 30mg (orally disintegrating) 30	30.00	MG	75,422	2,271,432
	P	8857E	Tablet 45mg (orally disintegrating) 30	30.00	MG	32,336	1,382,558
	P	8883M	Tablet 45mg 30	30.00	MG	210,252	9,003,469
	P	9365X	Tablet 15mg 30	30.00	MG	43,577	887,992
N06AX18	REBOXETINE
	P	8583R	Tablet 4mg (base) 60	8.00	MG	65,651	2,758,493
N06AX16	VENLAFAXINE
	P	8301X	Capsule 75mg (base) (modified release) 28	100.00	MG	1,207,106	57,006,599
	P	8302Y	Capsule 150mg (base) (modified release) 28	100.00	MG	1,387,701	85,088,024
	P	8868R	Capsule 37.5mg (base) (modified release) 28	100.00	MG	153,250	4,429,563
PSYCHOSTIMULANTS AND NOOTROPICS
CENTRALLY ACTING SYMPATHOMIMETICS

N06 - PSYCHOANALEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOANALEPTICS PSYCHOSTIMULANTS AND NOOTROPICS
N06BA09	ATOMOXETINE
	P	9092M	Capsule 10mg base 56	80.00	MG	3,622	804,105
	P	9093N	Capsule 18mg base 56	80.00	MG	3,787	828,785
	P	9094P	Capsule 25mg base 56	80.00	MG	7,366	1,628,050
	P	9095Q	Capsule 40mg base 56	80.00	MG	9,280	2,042,570
	P	9096R	Capsule 60mg base 56	80.00	MG	6,528	1,437,203
	P	9289X	Capsule 80mg base 28	80.00	MG	2,332	353,903
	P	9290Y	Capsule 100mg base 28	80.00	MG	910	134,180
N06BA02	DEXAMPHETAMINE SULPHATE
	P	1165H	Tablet 5mg	15.00	MG	227,222	6,053,795
N06BA04	METHYLPHENIDATE
	P	2172H	Tablet (extended release) 27mg 30	30.00	MG	41,066	2,375,497
	P	2276T	Capsule controlled release 20mg	30.00	MG	31,735	1,495,294
	P	2280B	Capsule controlled release 30mg	30.00	MG	30,682	1,741,565
	P	2283E	Capsule controlled release 40mg	30.00	MG	25,882	1,507,414
	P	2387P	Tablet (extended release) 18mg 30	30.00	MG	24,172	1,302,999
	P	2388Q	Tablet (extended release) 36mg 30	30.00	MG	80,541	5,258,404
	P	2432B	Tablet (extended release) 54mg 30	30.00	MG	80,676	5,918,020
	P	3440C	Capsule 10mg (modified release) 30	30.00	MG	907	33,461
	P	8839F	Tablet 10mg 100	30.00	MG	111,639	2,100,429
N06BA07	MODAFINIL
	A	17624	Tablet 100mg 30	0.30	GM	1,805	—
	P	8816B	Tablet 100mg 120	0.30	GM	7,674	2,374,996
ANTI-DEMENTIA DRUGS
ANTICHOLINESTERASES
N06DA02	DONEPEZIL
	P	8495D	Tablet 5mg 28	7.50	MG	61,575	9,814,112
	P	8496E	Tablet 10mg 28	7.50	MG	189,964	29,565,906
N06DA04	GALANTAMINE
	P	8770N	Tablet 8mg (base) (prolonged release) 28	16.00	MG	20,162	2,603,607
	P	8771P	Tablet 16mg (base) (prolonged release) 28	16.00	MG	72,077	10,859,789
	P	8772Q	Tablet 24mg (base) (prolonged release) 28	16.00	MG	18,887	3,363,375
N06DA03	RIVASTIGMINE
	P	8497F	Capsule 1.5mg 56	9.00	MG	1,888	305,086
	P	8498G	Capsule 3mg 56	9.00	MG	2,930	467,140
	P	8499H	Capsule 4.5mg 56	9.00	MG	1,537	239,445
	P	8500J	Capsule 6mg 56	9.00	MG	1,826	283,806
	P	8563Q	Oral solution 2mg (base) per mL 120mL	9.00	MG	168	30,878
	P	9161E	TD patch 9mg (release approx. 4.6mg per 24hrs) 30	9.50	MG	9,455	1,571,414
	P	9162F	TD patch 18mg (release approx. 9.5mg per 24hrs) 30	9.50	MG	18,346	3,046,538
OTHER ANTI-DEMENTIA DRUGS
N06DX01	MEMANTINE HYDROCHLORIDE
	P	1956Y	Tablet 10mg 56	20.00	MG	22,869	2,579,531

- PSYCHOANALEPTICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM PSYCHOANALEPTICS ANTI-DEMENTIA DRUGS
	P	2059J	Oral drops 10mg per g 50g	20.00	MG	289	31,173
	P	9306T	Tablet 20mg 28	20.00	MG	2,897	320,317

N07 - OTHER NERVOUS SYSTEM DRUGS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM OTHER NERVOUS SYSTEM DRUGS PARASYMPATHOMIMETICS ANTICHOLINESTERASES
N07AA02	PYRIDOSTIGMINE BROMIDE
	P	1959D	Tablet 60mg	180.00	MG	12,813	761,577
	P	2608G	Tablet 180mg (sustained release)	180.00	MG	2,304	266,995
	P	2724J	Tablet 10mg	180.00	MG	3,539	95,706
CHOLINE ESTERS
N07AB02	BETHANECHOL CHLORIDE
	P	1062X	Tablet 10mg	45.00	MG	6,523	160,927
DRUGS USED IN ADDICTIVE DISORDERS
DRUGS USED IN NICOTINE DEPENDENCE
N07BA01	NICOTINE
	P	4571N	Transdermal patch 7cm (releasing 7mg/24hr) 7	14.00	MG	237	13,330
	P	4572P	Transdermal patch 14cm (releasing 14mg/24hr) 7	14.00	MG	832	56,771
	P	4573Q	Transdermal patch 21cm (releasing 21mg/24hr) 7	14.00	MG	1,205	81,144
	P	4576W	Transdermal patch releasing 5mg/16hr 7	14.00	MG	200	9,915
	P	4577X	Transdermal patch releasing 10mg/16hr 7	14.00	MG	884	48,394
	P	4578Y	Transdermal patch releasing 15mg/16hr 7	14.00	MG	532	32,123
	P	9198D	Transdermal patch releasing 15mg/16hr 28	14.00	MG	2,100	115,216
N07BA03	VARENICLINE
	P	9128K	Pack tabs 0.5mg;tabs 1mg 14;tabs 1mg 28 (tartrate)	2.00	MG	332,771	34,528,309
	P	9129L	Tablet 1mg (as tartrate) 112	2.00	MG	183,299	42,648,590
DRUGS USED IN ALCOHOL DEPENDENCE
N07BB03	ACAMPROSATE
	P	8357W	Tablet 333mg (enteric coated)	2.00	GM	31,034	5,141,598
N07BB01	DISULFIRAM
	A	16345	Effervescent Tablet 200mg 30	—	—	5,211	—
N07BB04	NALTREXONE
	P	8370M	Tablet 50mg 30	50.00	MG	24,967	3,480,021
DRUGS USED IN OPIOID DEPENDENCE
N07BC01	BUPRENORPHINE
	P	6307Y	Tablet (sublingual) 400ug (as hydrochloride)	8.00	MG	3,687	—
	P	6308B	Tablet (sublingual) 2mg (as hydrochloride)	8.00	MG	7,091	—
	P	6309C	Sublingual tablet 8mg (base)	8.00	MG	6,924	—
N07BC51	BUPRENORPHINE with NALOXONE
	P	6470M	Tablet (sublingual) 2mg (as hydrochloride)-0.5mg (as hydrochloride) 28	—	—	9,614	—
	P	6471N	Tablet (sublingual) 8mg (as hydrochloride)-2mg (as hydrochloride) 28	—	—	25,783	—
N07BC02	METHADONE HYDROCHLORIDE
	P	1606M	Injection 10mg in 1mL	25.00	MG	842	101,748
	P	1609Q	Tablet 10mg	25.00	MG	90,423	3,411,985
	A	17513	Syrup 25mg per 5mL 200mL	25.00	MG	38,028	—
	P	5399E	Syrup 25mg per 5mL 200mL	25.00	MG	1,989	47,560
	P	5400F	Syrup 25mg per 5mL 200mL	25.00	MG	1,044	26,975
	P	6171T	Syrup 25mg per 5mL 200mL	25.00	MG	9,689	—

N07 - OTHER NERVOUS SYSTEM DRUGS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
NERVOUS SYSTEM OTHER NERVOUS SYSTEM DRUGS DRUGS USED IN ADDICTIVE DISORDERS
	P	6172W	Syrup 25mg per 5mL 1L	25.00	MG	888	—
ANTIVERTIGO PREPARATIONS
ANTIVERTIGO PREPARATIONS
N07CA01	BETAHISTINE
	A	16064	Tablet 16mg 25	24.00	MG	190,649	—
OTHER NERVOUS SYSTEM DRUGS
OTHER NERVOUS SYSTEM DRUGS
N07XX02	RILUZOLE
	P	8664B	Tablet 50mg 56	0.10	MG	7,419	5,069,280
N07XX06	TETRABENAZINE
	P	1330B	Tablet 25mg	0.10	GM	6,114	2,203,637

Australian Statistics on Medicines 2010

Table 1 - Nervous System

Department of Health and Aged Care

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry